Published on: 3/13/1999 Last Visited: 8/12/2001
Daniel Lednicer , Ph.D. B.S. Antioch College ; Ph.D. , Ohio State University ; Postdoctoral Fellow at Duke University. Dr. Lednicer has experience at G. D. Searle , Upjohn Co. , Mead Johnson & Co. , and Adria Laboratories. He was NIH Project Officer for synthesis of anti-tumor compounds and anti-HIV compounds and manufacture of dosage forms for clinical studies. Editor and Chapter author on numerous books on medicinal chemistry ; co-author of the first four volumes and sole author of the most recent volume of the well known series The Organic Chemistry of Drug Synthesis. Numerous positions with the American Chemical Society Division of Medicinal Chemistry , including Division Chairman and Scientific Program Chairman for the 16th national symposium. Authored more than 70 peer-refereed papers and invented more than 65 U.S. patents. He actively participates in new drug development at DTI and is a co-inventor on DTI's most recent patent.